Öykü Gülmez

Öykü Gülmez

Auto-generated profile, based on publicly available information

Öykü Gülmez

Başkent Üniverstesi İstanbul Hastanesi

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2018 in Balkan Medical Journal
Verified
Journal Article
Open access
FOFlora Ozkalayci
Flora Ozkalayci
ÖGÖykü Gülmez
Öykü Gülmez
BUBetül Uğur-Altun
Betül Uğur-Altun
Seithikurippu R. Pandi-PerumalSeithikurippu R. Pandi-Perumal
Seithikurippu R. Pandi-Perumal
AAArmağan Altun
Armağan Altun
Cardiovascular disease is one of the most frequent causes of mortality and morbidity worldwide. There have been many variables identified as risk factors for cardiovascular disease. During the recent years, the role of receptor activator of nuclear factor kappa B, receptor activator of nuclear factor kappa B ligand and osteoprotegerin system are getting more remarkable in the pathogenesis of cardiovascular disease. Besides its role in the regulation of bone resorption system, these molecules are found to be associated with the pathophysiology of cardiovascular disease. There are conflicting data about the impact of osteoprotegerin, a glycoprotein on the regulatory role in the cardiovascular system. The review aims to discuss the current knowledge and the role of osteoprotegerin in cardiovascular disease.

27 May 2008 in Journal of Clinical Ultrasound
Verified
Journal Article
Closed access
PDF file
OGOyku Gulmez
Oyku Gulmez
SPSeckin Pehlivanoglu
Seckin Pehlivanoglu
RTRiza Turkoz
Riza Turkoz
EDEbru Demiralay
Ebru Demiralay
BGBurcak Gumus
Burcak Gumus

30 June 2019 in Balıkesir Medical Journal
Verified
Journal Article
Closed access
FOFlora Ozkalayci
Flora Ozkalayci
ÖGÖykü Gülmez
Öykü Gülmez
AAArmağan ALTUN
Armağan ALTUN
Cardiovascular disease (CVD) is one of the most frequent cause of mortality and morbidity world-wide. Advanced age is one of the most important risk factor for progression of atherosclerosis and coronary artery disease (CAD) is often seen over 45-years in male and 55 years in female population. However, there is a significant increase in the prevalence of myocardial infarction (MI) in young population recently. The aim of this study is to identify the most prevalent risk factors for CAD in the young population who presented with cardiac complaints and underwent coronary angiography (CAG) and to determine the primary and secondary prevention strategies along with the treatment strategies. Method: Young patients who have had cardiac complaints and received CAG during the last 10 years were screened retrospectively. Patient demographics, clinical characteristics and medications were collected retrospectively from the review of the medical records and cardiac catheterization database. A total of 113 cases were enrolled to the study. In all patients CAG was performed. Subjects were then classified in to two main groups according to their needs for revascularisation. Those subjects who didn’t require coronary revascularisation after CAG were enrolled to the control group (Group 1); and those who needed coronary revascularisation were enrolled to the patient group (Group 2). SPSS 15.0 for Windows program was used for statistical analysis. For categorical variables descriptive statistics were; number and percentage. For numerical variables descriptive statistics were; mean, standard deviation, minimum, maximum, median. When the independent two-group comparisons of numerical variables provided normal distribution condition the Student's t test was performed, while Mann-Whitney U test was performed when the normal distribution condition was not met. Rates in independent groups were compared with Chi square test. Statistical significance level of alpha was accepted as p<0,05. Results: The prevalence of male gender was significantly higher than female gender among the groups (p=0.002). There was no statistically significant difference between groups in respect to mean value of BMI (p=0.105). Smoking and average number of cigarettes smoked was significantly higher in Group 2 patients (p<0.001; p=0.002). There were no statistically significant difference between the groups regarding to their additional co-morbidities.